Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | MIR33A | Human | (+)-catechin | decreases expression | EXP | | 6480464 | Catechin results in decreased expression of MIR33A mRNA | CTD | PMID:24165878 | MIR33A | Human | (-)-epigallocatechin 3-gallate | affects binding | EXP | | 6480464 | epigallocatechin gallate binds to MIR33A mRNA | CTD | PMID:24165878 | MIR33A | Human | (-)-epigallocatechin 3-gallate | decreases expression | EXP | | 6480464 | epigallocatechin gallate results in decreased expression of MIR33A mRNA | CTD | PMID:24165878 | MIR33A | Human | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of MIR33A mRNA | CTD | PMID:22113133 | MIR33A | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MIR33A mRNA | CTD | PMID:30096437 | MIR33A | Human | 2,5-hexanedione | increases expression | ISO | Mir33 (Rattus norvegicus) | 6480464 | 2 and 5-hexanedione results in increased expression of MIR33 mRNA | CTD | PMID:31760062 | MIR33A | Human | aflatoxin B1 | decreases expression | ISO | Mir33 (Rattus norvegicus) | 6480464 | Aflatoxin B1 results in decreased expression of MIR33 mRNA | CTD | PMID:24472605 | MIR33A | Human | aristolochic acid A | decreases expression | ISO | Mir33 (Rattus norvegicus) | 6480464 | aristolochic acid I results in decreased expression of MIR33 mRNA | CTD | PMID:27422293 | MIR33A | Human | arsenite(3-) | increases expression | EXP | | 6480464 | arsenite results in increased expression of MIR33A mRNA | CTD | PMID:22728250 | MIR33A | Human | atrazine | decreases expression | ISO | Mir33 (Rattus norvegicus) | 6480464 | Atrazine results in decreased expression of MIR33 mRNA | CTD | PMID:36841081 | MIR33A | Human | azoxystrobin | multiple interactions | ISO | Mir33 (Rattus norvegicus) | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIR33 mRNA | CTD | PMID:34626815 | MIR33A | Human | Benzo[k]fluoranthene | decreases expression | EXP | | 6480464 | benzo(k)fluoranthene results in decreased expression of MIR33A mRNA | CTD | PMID:23993976 | MIR33A | Human | bisphenol A | decreases expression | ISO | Mir33 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of MIR33 mRNA | CTD | PMID:28483554 | MIR33A | Human | bisphenol A | decreases methylation | EXP | | 6480464 | bisphenol A results in decreased methylation of MIR33A gene | CTD | PMID:31601247 | MIR33A | Human | bleomycin A2 | decreases expression | ISO | Mir33 (Rattus norvegicus) | 6480464 | Bleomycin results in decreased expression of MIR33 mRNA | CTD | PMID:25933445 | MIR33A | Human | cadmium dichloride | increases expression | ISO | Mir33 (Rattus norvegicus) | 6480464 | Cadmium Chloride results in increased expression of MIR33 mRNA | CTD | PMID:35525383 | MIR33A | Human | chloroform | decreases expression | ISO | Mir33 (Mus musculus) | 6480464 | Chloroform results in decreased expression of MIR33 mRNA | CTD | PMID:32105654 | MIR33A | Human | chlorpyrifos | multiple interactions | ISO | Mir33 (Rattus norvegicus) | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIR33 mRNA | CTD | PMID:34626815 | MIR33A | Human | formaldehyde | decreases expression | EXP | | 6480464 | Formaldehyde results in decreased expression of MIR33A mRNA | CTD | PMID:21147603 | MIR33A | Human | fructose | multiple interactions | ISO | Mir33 (Rattus norvegicus) | 6480464 | [Fructose co-treated with Streptozocin] results in increased expression of MIR33A mRNA and Ghrelin inhibits the reaction [[Fructose co-treated with Streptozocin] results in increased expression of MIR33A mRNA] | CTD | PMID:31468622 | MIR33A | Human | ghrelin | multiple interactions | ISO | Mir33 (Rattus norvegicus) | 6480464 | Ghrelin inhibits the reaction [[Fructose co-treated with Streptozocin] results in increased expression of MIR33A mRNA] | CTD | PMID:31468622 | MIR33A | Human | glyphosate | multiple interactions | ISO | Mir33 (Rattus norvegicus) | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIR33 mRNA | CTD | PMID:34626815 | MIR33A | Human | imidacloprid | multiple interactions | ISO | Mir33 (Rattus norvegicus) | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIR33 mRNA | CTD | PMID:34626815 | MIR33A | Human | Licochalcone B | decreases expression | EXP | | 6480464 | licochalcone B results in decreased expression of MIR33A mRNA | CTD | PMID:33647349 | MIR33A | Human | microcystin-LR | increases expression | EXP | | 6480464 | cyanoginosin LR results in increased expression of MIR33A mRNA | CTD | PMID:29518473 | MIR33A | Human | nitrofen | decreases expression | ISO | Mir33 (Rattus norvegicus) | 6480464 | nitrofen results in decreased expression of MIR33 mRNA | CTD | PMID:27041227 | MIR33A | Human | quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of MIR33A mRNA | CTD | PMID:24165878 | MIR33A | Human | quercetin | decreases expression | ISO | Mir33 (Rattus norvegicus) | 6480464 | Quercetin results in decreased expression of MIR33 mRNA | CTD | PMID:26432773 | MIR33A | Human | resveratrol | affects binding | EXP | | 6480464 | resveratrol binds to MIR33A mRNA | CTD | PMID:24165878 | MIR33A | Human | resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of MIR33A mRNA | CTD | PMID:24165878 | MIR33A | Human | silver atom | decreases expression | EXP | | 6480464 | Silver analog results in decreased expression of MIR33A mRNA | CTD | PMID:24974767 | MIR33A | Human | silver(0) | decreases expression | EXP | | 6480464 | Silver analog results in decreased expression of MIR33A mRNA | CTD | PMID:24974767 | MIR33A | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of MIR33A mRNA | CTD | PMID:25879800 | MIR33A | Human | streptozocin | multiple interactions | ISO | Mir33 (Rattus norvegicus) | 6480464 | [Fructose co-treated with Streptozocin] results in increased expression of MIR33A mRNA and Ghrelin inhibits the reaction [[Fructose co-treated with Streptozocin] results in increased expression of MIR33A mRNA] | CTD | PMID:31468622 | MIR33A | Human | tetraphene | decreases expression | EXP | | 6480464 | benz(a)anthracene results in decreased expression of MIR33A mRNA | CTD | PMID:23993976 | MIR33A | Human | thiabendazole | multiple interactions | ISO | Mir33 (Rattus norvegicus) | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIR33 mRNA | CTD | PMID:34626815 | MIR33A | Human | titanium dioxide | increases expression | ISO | Mir33 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of MIR33 mRNA | CTD | PMID:21259345 | MIR33A | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of MIR33A gene | CTD | PMID:29501571 | |